Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis


Goodin D. S. , Biermann L. D. , Bohlega S., Boiko A., Chofflon M., Gebeily S., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.23, no.11, pp.2823-2832, 2007 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 11
  • Publication Date: 2007
  • Doi Number: 10.1185/03007x233007
  • Journal Name: CURRENT MEDICAL RESEARCH AND OPINION
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.2823-2832

Abstract

Background: As results from an increasing number of clinical trials with disease-modifying drugs (DMDs) in multiple sclerosis (MS) become available, the challenge for the treating is how to decide on the appropriate therapy for an individual patient.